Zylö Therapeutics
PrivateLast Round
Grant
May 31, 2023
Total Funding Raised
$13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Zylö Therapeutics is a biotechnology company developing a topical delivery system using engineered amorphous silica particles to encapsulate compounds for sustained release.
Sector
Healthcare & Life Sciences
Verticals
Advanced Materials, Biotechnology, Fashion & Beauty, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zylö Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Zylö Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 31, 2023 | ||||
| Grant | Aug 19, 2022 | ||||
| Series B | Jun 4, 2022 | ||||
| VC Round | Dec 7, 2021 | ||||
| Series A | Sep 21, 2019 |
Zylö Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| United States Department of Defense | Grant |
| Chemical Angel Network | Series A |
| Ariel Savannah Angel Partners | Series A |
| SC Launch | Series A, VC Round, Series B |
| Harvard Business School Alumni Angels of Greater New York | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 70% MoM.
- Feb 1, 2026
Monthly visitors increased 93% MoM.
Zylö Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zylö Therapeutics's valuation, stock price, and market status.